Biologics/Update·FDA Vaccines, Blood & Biologics

eSubmitter Application History

MediumPublished May 21, 2026· AI-analyzed May 24, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The FDA has updated the application history for its eSubmitter software, providing a reverse chronological record of all updates by version number.

Who it affects

Manufacturers of biological products, vaccines, and blood products who use the eSubmitter tool for electronic regulatory filings.

Why it matters

Access to version history is essential for ensuring that electronic submissions are prepared using supported software versions. Failure to maintain the appropriate version may result in technical rejection or processing errors during the submission of biologics license applications or other regulatory filings. This update indicates a commitment to transparency regarding the technical evolution of the agency's data intake portals.

Practical takeaway

Regulatory teams should verify that their current internal installation of eSubmitter matches the latest version in the FDA history log. IT and QA departments should document software version updates in their change control logs to ensure submissions are compatible with the agency's current processing specifications.

FDA source material

History of all updates to the application software in reverse chronological order by version number

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.